ARCHIVES

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

This article is from The Cancer Letter archive.

Vol. 21 No. 36 | September 22, 1995

Download PDF Visit The Full Archive

Related Articles

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

In Brief: Moloney, Manaher, 11 Other NCI Staff Members Retire; Terry Takes Leave From Immunology Jobs

March 7, 1980

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Final Issues Of 1982

December 10, 1982

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

February 1, 2013

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984